Ipsen announces changes to its Executive Committee
PARIS, FRANCE, 23 July 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a…
A year on, Paris 2024 belongs to everyone
22 July 2025 - A year ago, beneath a stormy summer sky, history…
EssilorLuxottica to acquire PUcores division dedicated to the development, manufacturing and sale of ophthalmic lens materials
EssilorLuxottica to acquire PUcore’s division dedicated to the development, manufacturing and sale…
Xinhua Silk Road: Ancient ethnic Chinese legacy revealing cultural fusion inscribed as UNESCO World Heritage
BEIJING, July 17, 2025 /PRNewswire/ -- The Xixia Imperial Tombs were inscribed on…
Chteau Galoupet unveils an exceptional brand home and launches its latest cuve
PARIS, July 17, 2025 /PRNewswire/ -- In July 2025, Château Galoupet, a historic…
IOC documentary series starring Simone Biles nominated for Primetime Emmy Award
16 July 2025 - The acclaimed Netflix documentary series following seven-time Olympic champion…
The Seine Reopens: How the Olympic Games Helped Paris Reclaim Its River
10 July 2025 - For the first time in over a century, Parisians…
Countries Urged to Establish National Refrigeration Committees to Tackle Food, Health, Animals and Climate Challenges
PARIS, June 26, 2025 /PRNewswire/ -- On the occasion of World Refrigeration…
Monthly information on share capital and company voting rights
PARIS, July 04, 2025 (GLOBE NEWSWIRE) -- (Article 223-16 of General Regulation…
AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3…